Evaluation of Sulfobutylether-β-Cyclodextrin Exposure in a Critically Ill Patient Receiving Intravenous Posaconazole While Undergoing Continuous Venovenous Hemofiltration

Item

http://www.wikidata.org/entity/Q36076106

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Evaluation of Sulfobutylether- ...... uous Venovenous Hemofiltration

@ast

Evaluation of Sulfobutylether- ...... uous Venovenous Hemofiltration

@en

type

Item

label

Evaluation of Sulfobutylether- ...... uous Venovenous Hemofiltration

@ast

Evaluation of Sulfobutylether- ...... uous Venovenous Hemofiltration

@en

prefLabel

Evaluation of Sulfobutylether- ...... uous Venovenous Hemofiltration

@ast

Evaluation of Sulfobutylether- ...... uous Venovenous Hemofiltration

@en

P1476

Evaluation of Sulfobutylether- ...... uous Venovenous Hemofiltration

@en

P2093

Amanda A Morris

http://www.w3.org/2001/XMLSchema#string

Joseph E Rower

http://www.w3.org/2001/XMLSchema#string

Scott W Mueller

http://www.w3.org/2001/XMLSchema#string

Taylor Washburn

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America

Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial

Phase 1B study of the pharmacokinetics and safety of posaconazole intravenous solution in patients at risk for invasive fungal disease.

Pharmacokinetics of sulfobutylether-beta-cyclodextrin and voriconazole in patients with end-stage renal failure during treatment with two hemodialysis systems and hemodiafiltration.

Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.

Posaconazole serum concentrations among cardiothoracic transplant recipients: factors impacting trough levels and correlation with clinical response to therapy

Evaluation of sulfobutylether-β-cyclodextrin (SBECD) accumulation and voriconazole pharmacokinetics in critically ill patients undergoing continuous renal replacement therapy

Diagnosis and treatment of mucormycosis in patients with hematological malignancies: guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3).

Review of the basic and clinical pharmacology of sulfobutylether-beta-cyclodextrin (SBECD).

Pharmacokinetics, safety and tolerance of voriconazole in renally impaired subjects: two prospective, multicentre, open-label, parallel-group volunteer studies.

P304

6653-6656

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1128/AAC.01493-15

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Tyree H. Kiser

P577

2015-08-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26259790

http://www.w3.org/2001/XMLSchema#string

P932

4576128

http://www.w3.org/2001/XMLSchema#string